Hydroxysafflor yellow A

CAS No. 78281-02-4

Hydroxysafflor yellow A( Hydroxysafflor yellow A | Safflomin A )

Catalog No. M15954 CAS No. 78281-02-4

Hydroxysafflor yellow A inhibited adipogenesis by increasing HSL promoter activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
10MG 82 In Stock
25MG 148 In Stock
50MG 254 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hydroxysafflor yellow A
  • Note
    Research use only, not for human use.
  • Brief Description
    Hydroxysafflor yellow A inhibited adipogenesis by increasing HSL promoter activities.
  • Description
    Hydroxysafflor yellow A inhibited adipogenesis by increasing HSL promoter activities. Hydroxysafflor yellow A can effectively protect the liver from long-term alcohol injury by enhancing antioxidant capacity and inhibiting the expression of TGF-β. It prevents steroid-induced avascular necrosis of femoral head by inhibiting primary bone marrow-derived mesenchymal stromal cells. Also, Hydroxysafflor yellow A has anti-tumor effects.
  • In Vitro
    Cell Migration Assay Cell Line:VSMCs Concentration:0.1, 1, 10,100 μM Incubation Time:24 h Result: Inhibited LPS-induced VSMCs proliferation and migration with the concentration of 10 μM.Western Blot Analysis Cell Line:VSMCs Concentration:10 μM Incubation Time:24 h Result:Inhibited LPS-induced upregulation of pro-inflammatory factors (TNF-α, IL-6, and IL-8).Inhibited LPS-induced upregulation of TLR-4 and activation of Rac1/Akt pathway.Cell Viability Assay Cell Line:3T3-L1 Concentration:0.01, 0.1, 1, 10 mg/L Incubation Time:4, 8, 24, 48, 72, 96 h Result:Inhibit the cell viability in a dose and time-dependent manner.Apoptosis Analysis Cell Line:HepG2, Huh7 Concentration:20, 40, 80, 160 μM Incubation Time:24 hResult:Suppressed the growth and induced apoptotic cell death in both concentration and time-dependent manners.
  • In Vivo
    Animal Model:Liver injury model induced by alcoholDosage:2.5 or 10 mg/kg Administration: i.p. daily for 6 weeks Result:Decreased the level of ALT and AST. Decreased the levels of HA, LN, and III-C.Increased the activities of SOD and GPx and decreased the level of TGF-β1 expression.Animal Model:Chronic obstructive pulmonary disease (COPD)Dosage:30, 48, 76.8 mg/kg Administration:i.p.Result:Inhibited the elevated IL-6, IL-1β, TNF-α, ICAM-1 and VCAM-1 mRNA Levels.Inhibited the increased phosphorylation and NF-κB p65 levels.
  • Synonyms
    Hydroxysafflor yellow A | Safflomin A
  • Pathway
    TGF-beta/Smad
  • Target
    TGFBR
  • Recptor
    TGFβ
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    78281-02-4
  • Formula Weight
    612.53338
  • Molecular Formula
    C27H32O16
  • Purity
    >98% (HPLC)
  • Solubility
    Pyridine, Methanol, Ethanol
  • SMILES
    O=C1C([C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)=C(O)C(O)([C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)C(O)=C1C(/C=C/C4=CC=C(O)C=C4)=O
  • Chemical Name
    3,4,5-trihydroxy-2-((E)-3-(4-hydroxyphenyl)acryloyl)-4-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)-6-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)cyclohexa-2,5-dien-1-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhu HJ, et al. Cytotechnology. 2015 Oct;67(5):885-92.
molnova catalog
related products
  • Hydroxysafflor yello...

    Hydroxysafflor yellow A inhibited adipogenesis by increasing HSL promoter activities.

  • A 83-01

    A potent, selective TGF-beta type I receptor ALK-5, ALK-4 and ALK-7 inhibitor with IC50 of 12, 45 and 7.5 nM, respectively.

  • Monocrotaline

    Extracted from Legume Crotalaria assamica;Suitability:Methanol,ethanol,chloroform;Store the product in sealed,cool and dry condition